Mahmut Çöker

2.3k total citations
99 papers, 1.1k citations indexed

About

Mahmut Çöker is a scholar working on Physiology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Mahmut Çöker has authored 99 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Physiology, 28 papers in Molecular Biology and 25 papers in Clinical Biochemistry. Recurrent topics in Mahmut Çöker's work include Lysosomal Storage Disorders Research (27 papers), Metabolism and Genetic Disorders (25 papers) and Glycogen Storage Diseases and Myoclonus (10 papers). Mahmut Çöker is often cited by papers focused on Lysosomal Storage Disorders Research (27 papers), Metabolism and Genetic Disorders (25 papers) and Glycogen Storage Diseases and Myoclonus (10 papers). Mahmut Çöker collaborates with scholars based in Türkiye, United States and Germany. Mahmut Çöker's co-authors include Sema Kalkan Uçar, Şükran Darcan, Damla Gökşen, Ebru Canda, Timur Köse, Eser Yıldırım Sözmen, Christian J. Hendriksz, Christine Lavery, Mohit Jain and Ferda Özkınay and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Journal of Bone and Mineral Research.

In The Last Decade

Mahmut Çöker

88 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahmut Çöker Türkiye 19 311 306 169 157 146 99 1.1k
Michel Tchan Australia 19 478 1.5× 418 1.4× 146 0.9× 177 1.1× 249 1.7× 76 1.1k
Serena Gasperini Italy 16 443 1.4× 223 0.7× 282 1.7× 83 0.5× 185 1.3× 64 880
J. Schaub Germany 20 200 0.6× 228 0.7× 284 1.7× 162 1.0× 173 1.2× 57 1.0k
Alan Bevington United Kingdom 19 291 0.9× 351 1.1× 67 0.4× 77 0.5× 75 0.5× 72 1.3k
Konrad Szymañski Poland 18 140 0.5× 182 0.6× 128 0.8× 103 0.7× 36 0.2× 44 1.3k
Anna Witasp Sweden 22 288 0.9× 352 1.2× 88 0.5× 139 0.9× 69 0.5× 49 1.5k
Nick Shaw United Kingdom 20 153 0.5× 257 0.8× 106 0.6× 301 1.9× 33 0.2× 55 1.5k
Alison Skrinar United States 21 414 1.3× 202 0.7× 426 2.5× 216 1.4× 21 0.1× 50 1.5k
Chanika Phornphutkul United States 22 372 1.2× 728 2.4× 291 1.7× 324 2.1× 495 3.4× 56 2.0k
Elaine Liu Canada 23 103 0.3× 416 1.4× 73 0.4× 111 0.7× 29 0.2× 49 1.7k

Countries citing papers authored by Mahmut Çöker

Since Specialization
Citations

This map shows the geographic impact of Mahmut Çöker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmut Çöker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmut Çöker more than expected).

Fields of papers citing papers by Mahmut Çöker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmut Çöker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmut Çöker. The network helps show where Mahmut Çöker may publish in the future.

Co-authorship network of co-authors of Mahmut Çöker

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmut Çöker. A scholar is included among the top collaborators of Mahmut Çöker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmut Çöker. Mahmut Çöker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yazıcı, Havva, et al.. (2023). Glycosaminoglycan-induced proinflammatory cytokine levels as disease marker in mucopolysaccharidosis. Cytokine. 173. 156410–156410.
2.
Yazıcı, Havva, Ebru Canda, Sema Kalkan Uçar, & Mahmut Çöker. (2022). Severe perinatal hypophosphatasia case with a novel mutation. Archivos Argentinos de Pediatria. 120(1). e21–e24.
3.
Yazıcı, Havva, et al.. (2022). Rare coexistence of Tay-Sachs disease, coarctation of the aorta and grade V vesicoureteral reflux. Archivos Argentinos de Pediatria. 120(1). e25–e28. 1 indexed citations
4.
Yazıcı, Havva, Ebru Canda, Sema Kalkan Uçar, et al.. (2021). Tetrahydrobiopterin deficiencies: Lesson from clinical experience. JIMD Reports. 59(1). 42–51. 11 indexed citations
5.
Jones, Simon, et al.. (2021). Open-label phase 1/2 study of vestronidase alfa for mucopolysaccharidosis VII. Molecular Genetics and Metabolism Reports. 28. 100774–100774. 2 indexed citations
6.
Çağlayan, Ahmet Okay, Tufan Çankaya, Najim Ameziane, et al.. (2020). Biallelic ZNF335 mutations cause basal ganglia abnormality with progressive cerebral/cerebellar atrophy. Journal of Neurogenetics. 35(1). 23–28. 3 indexed citations
7.
Canda, Ebru, et al.. (2019). Two siblings with Gaucher type 3c: different clinical presentations. Journal of Pediatric Endocrinology and Metabolism. 32(5). 533–536. 4 indexed citations
8.
Yılmaz, Suzan Güven, Hüseyin Önay, Melis Palamar, et al.. (2017). A novel mutation and in vivo confocal microscopic findings in Fabry disease. Saudi Journal of Ophthalmology. 31(1). 45–47. 7 indexed citations
9.
Çöker, Mahmut. (2014). [LDL apheresis in the treatment of familial hypercholesterolemia].. PubMed. 42 Suppl 2. 32–46. 3 indexed citations
10.
Durmaz, Asude, Tahir Atık, Hüseyin Önay, et al.. (2014). Molecular analysis in X-linked adrenoleukodystrophy patients: identification of a novel mutation. Metabolic Brain Disease. 29(3). 809–812.
11.
Hu, Liyan, Carmen Dı́ez-Fernández, Véronique Rüfenacht, et al.. (2014). Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: Characterization of a founder mutation by use of recombinant CPS1 from insect cells expression. Molecular Genetics and Metabolism. 113(4). 267–273. 9 indexed citations
12.
Güneş, Sezgin, Özge Altun Köroğlu, Mehmet Yalaz, et al.. (2013). Reference intervals of α-glycosidase, β-glycosidase, and α-galactosidase in dried blood spot in a Turkish newborn population. European Journal of Pediatrics. 172(9). 1221–1227. 4 indexed citations
13.
Karaca, Emin, et al.. (2012). Analysis of the β-glucocerebrosidase gene in Turkish Gaucher disease patients: mutation profile and description of a novel mutant allele. Journal of Pediatric Endocrinology and Metabolism. 25(9-10). 957–62. 4 indexed citations
14.
Çöker, Mahmut, et al.. (2009). Low Density Lipoprotein Apheresis in Pediatric Patients With Homozygous Familial Hypercholesterolemia. Therapeutic Apheresis and Dialysis. 13(2). 121–128. 19 indexed citations
15.
Uçar, Sema Kalkan, Özge Altun Köroğlu, Mehmet Yalaz, et al.. (2009). Titration of betaine therapy to optimize therapy in an infant with 5,10-methylenetetrahydrofolate reductase deficiency. European Journal of Pediatrics. 169(2). 241–243. 7 indexed citations
16.
Uçar, Sema Kalkan, Mahmut Çöker, Sara Habif, et al.. (2009). The first use of N-carbamylglutamate in a patient with decompensated maple syrup urine disease. Metabolic Brain Disease. 24(3). 409–414. 16 indexed citations
17.
Uçar, Sema Kalkan, et al.. (2009). An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III. Journal of Trace Elements in Medicine and Biology. 24(1). 42–45. 21 indexed citations
18.
Alpöz, Ali Rıza, et al.. (2006). The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI): A case report. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 101(5). 632–637. 40 indexed citations
20.
Çöker, Mahmut, et al.. (2002). Carnitine Metabolism in Diabetes Mellitus. Journal of Pediatric Endocrinology and Metabolism. 15(6). 841–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026